Colorado MEDtech Inc. Completes Acquisition of Novel Biomedical Inc.BOULDER, Colo.--(BUSINESS WIRE)--March 3, 1997--Colorado MEDtech Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CMED CMED Coordinated Medical Emergency Direction CMED Central Massachusetts Emergency Dispatch ) today announced it has completed the acquisition of Novel Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Inc. The purchase was completed for approximately $1.3 million cash, issuance of 70,000 common shares and approximately 294,000 five-year non-qualified common stock options of CMED, resulting in a total purchase value of approximately $1.9 million. Novel, located in Plymouth, Minn., had revenues of approximately $2.1 million and net income of approximately $300,000 for the year ended Dec. 31, 1996. The company specializes in the custom design, development and manufacture of unique disposable medical devices, primarily catheters, used in angioplasty, minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. , electrophysiology and infertility. Jonathan Kagan, founder, will remain as president of Novel. "This is a strategic acquisition," said John V. Atanasoff, Colorado MEDtech president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , "which will enhance our design, development and manufacturing capabilities and will also provide the basis for the development of proprietary interventional medical devices. We plan to grow the Novel operation in Minnesota by continued expansion of the base business and development of unique proprietary products." Colorado MEDtech is an integrated custom product development and manufacturing services company specializing in the design, development and manufacture of electronic and electromechanical products and software systems for the medical device industry. CONTACT: Colorado MEDtech Inc. John V. Atanasoff, 303/530-2660 (President & CEO) Bruce L. Arfmann, 303/530-2660 (CFO See Chief Financial Officer. ) cmed@rela.uucp.netcom.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion